Correction: Coley Pharmaceutical story |
|
|
|
Published
:
Fri, 29 Jun 2007 20:16 |
WELLESLEY, Mass. (AP) - In a June 28 story about a licensing agreement between Coley Pharmaceutical Group and Dynavax Technologies, The Associated Press erroneously reported terms of the deal. The hepatitis B vaccine Heplisav is being developed by Dynavax, not Coley. Dynavax, not Coley, expects to submit the vaccine to the Food and Drug Administration next year.Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
|
|
|
|